Oscar Health said it will raise its full-year 2026 outlook for medical costs and operating earnings ahead of its Investor Day on Wednesday. The health insurer now expects its medical loss ratio to range between 81% and 82%, a 50-basis-point improvement from its previous forecast of 81.5% to 82.5%. The company also raised its earnings from operations outlook by $100M to $600M-$800M, from the earlier range of $500M-$700M. Oscar reaffirmed its full-year revenue forecast of $18.7B to $19B and expects its SG&A expense ratio to remain between 15.6% and 16.1%. The company is scheduled to begin its 2026 Investor Day at 9 a.m. ET Wednesday, where it plans to outline its strategy, long-term financial targets, and updated outlook.
Oscar Health IncOscar Health raised its 2026 medical loss ratio and operating earnings outlook, improving its margin and profit forecast.
